Waddell & Reed Financial’s BioAmber Inc. BIOA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2,900,000
| Closed | -$124K | – | 576 |
|
|
2017
Q1 | $124K | Hold |
2,900,000
| – | – | ﹤0.01% | 535 |
|
|
2016
Q4 | $1.77M | Hold |
2,900,000
| – | – | ﹤0.01% | 551 |
|
|
2016
Q3 | $1.33M | Hold |
2,900,000
| – | – | ﹤0.01% | 571 |
|
|
2016
Q2 | $1.1M | Hold |
2,900,000
| – | – | ﹤0.01% | 572 |
|
|
2016
Q1 | $5.09M | Hold |
2,900,000
| – | – | 0.01% | 483 |
|
|
2015
Q4 | $4.09M | Hold |
2,900,000
| – | – | 0.01% | 511 |
|
|
2015
Q3 | $5.16M | Hold |
2,900,000
| – | – | 0.01% | 492 |
|
|
2015
Q2 | $5.57M | Hold |
2,900,000
| – | – | 0.01% | 501 |
|
|
2015
Q1 | $4.61M | Hold |
2,900,000
| – | – | 0.01% | 506 |
|
|
2014
Q4 | $4.58M | Hold |
2,900,000
| – | – | 0.01% | 496 |
|
|
2014
Q3 | $7.11M | Hold |
2,900,000
| – | – | 0.01% | 453 |
|
|
2014
Q2 | $7.29M | Buy |
2,900,000
+150,000
| +5% | +$341K | 0.01% | 467 |
|
|
2014
Q1 | $5.86M | Hold |
2,750,000
| – | – | 0.01% | 501 |
|
|
2013
Q4 | $2.01M | Hold |
2,750,000
| – | – | ﹤0.01% | 544 |
|
|
2013
Q3 | $2.2M | Hold |
2,750,000
| – | – | ﹤0.01% | 528 |
|
|
2013
Q2 | $1.51M | Buy |
+2,750,000
| New | +$1.74M | ﹤0.01% | 512 |
|
Waddell & Reed Financial's BIOA.WS Position: Q2 2017 in Review
Waddell & Reed Financial sold out of BioAmber Inc. (BIOA.WS) in Q2 2017, closing a stake of 2,900,000 shares — an estimated $124K sold.
Waddell & Reed Financial first reported a position in BIOA.WS in Q2 2013 and held it in 16 quarters. The position peaked at $7.29M in Q2 2014. 0 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2017.
- Waddell & Reed Financial reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
- Waddell & Reed Financial sold 2,900,000 BioAmber Inc. shares in Q2 2017, an estimated $124K.
- Waddell & Reed Financial first reported a position in BioAmber Inc. in Q2 2013 and held it in 16 quarters.
- Waddell & Reed Financial's BioAmber Inc. position peaked at $7.29M in Q2 2014.
- 0 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.
Based on Waddell & Reed Financial's 13F filing for Q2 2017, filed 14 Aug 2017.